These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 20389132

  • 21. Attributions for psychobiological changes in ecstasy/MDMA and other polydrug users.
    Soar K, Parrott A, Turner J.
    J Psychopharmacol; 2009 Sep; 23(7):745-58. PubMed ID: 18635698
    [Abstract] [Full Text] [Related]

  • 22. Depressive symptomatology in young adults with a history of MDMA use: a longitudinal analysis.
    Falck RS, Wang J, Carlson RG.
    J Psychopharmacol; 2008 Jan; 22(1):47-54. PubMed ID: 18187532
    [Abstract] [Full Text] [Related]

  • 23. [A case of acute psychotic episode after a single dose of ecstasy].
    Vaiva G, Bailly D, Boss V, Thomas P, Lestavel P, Goudemand M.
    Encephale; 2001 Jan; 27(2):198-202. PubMed ID: 11407274
    [Abstract] [Full Text] [Related]

  • 24. Neuropsychological evidence of a relatively selective profile of temporal dysfunction in drug-free MDMA ("ecstasy") polydrug users.
    Fox HC, McLean A, Turner JJ, Parrott AC, Rogers R, Sahakian BJ.
    Psychopharmacology (Berl); 2002 Jul; 162(2):203-14. PubMed ID: 12110998
    [Abstract] [Full Text] [Related]

  • 25. Cognitive performance in recreational ecstasy polydrug users: a two-year follow-up study.
    de Sola Llopis S, Miguelez-Pan M, Peña-Casanova J, Poudevida S, Farré M, Pacifici R, Böhm P, Abanades S, Verdejo García A, Langohr K, Zuccaro P, de la Torre R.
    J Psychopharmacol; 2008 Jul; 22(5):498-510. PubMed ID: 18208910
    [Abstract] [Full Text] [Related]

  • 26. Patterns of use and harm reduction practices of ecstasy users in Australia.
    Allott K, Redman J.
    Drug Alcohol Depend; 2006 Apr 28; 82(2):168-76. PubMed ID: 16226850
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Pathways to ecstasy use in young adults: anxiety, depression or behavioural deviance?
    Alati R, Kinner SA, Hayatbakhsh MR, Mamun AA, Najman JM, Williams GM.
    Drug Alcohol Depend; 2008 Jan 01; 92(1-3):108-15. PubMed ID: 17850992
    [Abstract] [Full Text] [Related]

  • 32. [Prospective study of favorable factors in follow-up of drug addicted patients--apropos of 257 patients of the Cassini Center in Paris].
    Goeb JL, Coste J, Bigot T, Ferrand I.
    Encephale; 2000 Jan 01; 26(6):11-20. PubMed ID: 11217533
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Is emotional intelligence impaired in ecstasy-polydrug users?
    Craig L, Fisk JE, Montgomery C, Murphy PN, Wareing M.
    J Psychopharmacol; 2010 Feb 01; 24(2):221-31. PubMed ID: 18801831
    [Abstract] [Full Text] [Related]

  • 35. Recreational ecstasy use and depression.
    Guillot C, Greenway D.
    J Psychopharmacol; 2006 May 01; 20(3):411-6. PubMed ID: 16574715
    [Abstract] [Full Text] [Related]

  • 36. Patterns of ecstasy use and associated harm: results of a Brazilian online survey.
    de Almeida SP, Garcia-Mijares M, Silva MT.
    Subst Use Misuse; 2009 May 01; 44(14):2014-27. PubMed ID: 20001692
    [Abstract] [Full Text] [Related]

  • 37. Prevalence and correlates of current depressive symptomatology among a community sample of MDMA users in Ohio.
    Falck RS, Wang J, Carlson RG, Siegal HA.
    Addict Behav; 2006 Jan 01; 31(1):90-101. PubMed ID: 15922511
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Symptoms of ecstasy dependence and correlation with psychopathology in Taiwanese adolescents.
    Yen CF, Hsu SY.
    J Nerv Ment Dis; 2007 Oct 01; 195(10):866-9. PubMed ID: 18043529
    [Abstract] [Full Text] [Related]

  • 40. Qualitative review of serotonin syndrome, ecstasy (MDMA) and the use of other serotonergic substances: hierarchy of risk.
    Silins E, Copeland J, Dillon P.
    Aust N Z J Psychiatry; 2007 Aug 01; 41(8):649-55. PubMed ID: 17620161
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.